Pengcheng Zhang, K. Dou, Zhao-rui Yang, Ruohan Zhang, Hongtao Zhang, W. Peng, Yanbing Cao, Weiming Li
{"title":"Non-alcoholic fatty liver disease and liver transplantation","authors":"Pengcheng Zhang, K. Dou, Zhao-rui Yang, Ruohan Zhang, Hongtao Zhang, W. Peng, Yanbing Cao, Weiming Li","doi":"10.3760/CMA.J.ISSN.1007-8118.2020.02.017","DOIUrl":null,"url":null,"abstract":"Non-alcoholic fatty liver disease (NAFLD) is characterized by increased fat depositions in the liver while the patients do not have drinking history. NAFLD has a prevalence of 10%~40% in global, 25%~26% in Western populations. From 2004 to 2013, the numbers of new patients on the waitlist who had NASH increased by 170% in America. The prevalence of NAFLD in China is 20%. With the decrease of HBV and HCV and the increase of diabetes mellitus type 2 and obesity, NAFLD will become the most common chronic liver disease in China over the next 20 years. NAFLD related end-stage liver disease will become the most common indication of liver transplantation. In this paper, the epidemiological features, pathogenesis, indication and prognosis of liver transplantation are reviewed. \n \nKey words: \nLiver transplantation; Metabolic syndrome; Fatty liver, non-alcoholic","PeriodicalId":10021,"journal":{"name":"中华肝胆外科杂志","volume":"26 1","pages":"155-157"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肝胆外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2020.02.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Non-alcoholic fatty liver disease (NAFLD) is characterized by increased fat depositions in the liver while the patients do not have drinking history. NAFLD has a prevalence of 10%~40% in global, 25%~26% in Western populations. From 2004 to 2013, the numbers of new patients on the waitlist who had NASH increased by 170% in America. The prevalence of NAFLD in China is 20%. With the decrease of HBV and HCV and the increase of diabetes mellitus type 2 and obesity, NAFLD will become the most common chronic liver disease in China over the next 20 years. NAFLD related end-stage liver disease will become the most common indication of liver transplantation. In this paper, the epidemiological features, pathogenesis, indication and prognosis of liver transplantation are reviewed.
Key words:
Liver transplantation; Metabolic syndrome; Fatty liver, non-alcoholic
期刊介绍：
Chinese Journal of Hepatobiliary Surgery is an academic journal organized by the Chinese Medical Association and supervised by the China Association for Science and Technology, founded in 1995. The journal has the following columns: review, hot spotlight, academic thinking, thesis, experimental research, short thesis, case report, synthesis, etc. The journal has been recognized by Beida Journal (Chinese Journal of Humanities and Social Sciences).
Chinese Journal of Hepatobiliary Surgery has been included in famous databases such as Peking University Journal (Chinese Journal of Humanities and Social Sciences), CSCD Source Journals of China Science Citation Database (with Extended Version) and so on, and it is one of the national key academic journals under the supervision of China Association for Science and Technology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
